Skip to main content

Tower Research Capital LLC (TRC)

Position in NBIX — Neurocrine Biosciences Inc

CIK 1533421 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$536,181
+$104,735 QoQ
Shares Held
4,070
+33.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $6,300,576 across 59 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
4,070 $536,181

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $536,181 4,070
2025-12-31 $431,446 3,042
2025-09-30 $743,732 5,298
2025-06-30 $361,107 2,873
2025-03-31 $710,383 6,423
2024-12-31 $1,444,169 10,580
2024-09-30 $260,051 2,257
2024-06-30 $367,991 2,673
2024-03-31 $867,516 6,290
2023-12-31 $1,864,799 14,153
2023-09-30 $1,163,812 10,345
2023-06-30 $1,131,882 12,003
2023-03-31 $603,271 5,960
2022-12-31 $340,881 2,854
2022-09-30 $522,765 4,922
2022-06-30 $1,481,402 15,197
2022-03-31 $1,023,468 10,917
2021-12-31 $1,199,022 14,078
2021-09-30 $597,711 6,232
2021-06-30 $1,685,387 17,318
2021-03-31 $1,343,994 13,820
2020-12-31 $1,278,925 13,343
2020-09-30 $284,152 2,955
2020-06-30 $47,702 391
2020-03-31 $6,058 70